Skip to content

Persona® 42-5046-062-01Recalls & reported problems

Zimmer, Inc. · Class 2 · Implant

All models of PERSONA (364)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00889024562554), received between Mar 18, 2022 and Mar 14, 2024 — classified as 4 injuries.

The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K181947, K191625); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Loosening of Implant Not Related to Bone-Ingrowth2
  • Insufficient Device Problem Information1

Patient problems

  • Pain3
  • Failure of Implant2
  • Joint effusion1
  • Loss of Range of Motion1
  • No Clinical Signs, Symptoms or Conditions1
  • Radiolucent Lines1
  • Swelling/ Edema1
  • Synovitis1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 14, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT UNDERWENT AN ASPIRATION, ARTHROCENTESIS AND TRIAMCINOLONE ACETONIDE INJECTIONS TO ADDRESS PAIN, SYNOVITIS, LOSS OF RANGE OF MOTION, JOINT EFFUSION AND SWELLING APPROXIMATELY SIX MONTHS FOLLOWING LEFT KNEE ARTHROPLASTY. INITIAL OPERATIVE NOTES NOTED NO INTRAOPERATIVE COMPLICATIONS.

    Patient problems: Joint effusion; Loss of Range of Motion; Pain; Swelling/ Edema; Synovitis

    MAUDE report 18901924 ↗
  • InjuryMay 17, 2023Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth

    NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

    Patient problems: Failure of Implant; Pain; Radiolucent Lines

    MAUDE report 16947984 ↗
  • InjuryMar 23, 2022Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    IT WAS REPORTED PATIENT UNDERWENT A REVISION PROCEDURE ON UNKNOWN DATE DUE TO UNKNOWN REASON. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE BEEN MADE; HOWEVER, NO MORE IS AVAILABLE AT THIS TIME.

    Patient problems: No Clinical Signs, Symptoms or Conditions; Unspecified Infection

    MAUDE report 13869599 ↗
  • InjuryMar 18, 2022Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth

    IT WAS REPORTED THAT THE PATIENT UNDERWENT A LEFT KNEE ARTHROPLASTY REVISION TO ADDRESS PAIN AND POSSIBLE LOOSENING APPROXIMATELY TWO (2) MONTHS POST-OPERATIVELY. INITIAL OPERATIVE NOTES NOTED THE PATIENT WAS REVISED DUE TO INFECTION AND ADDITIONAL ANTIBIOTICS WERE ADMINISTERED IN THE BONE CEMENT. THE SURGEON NOTED THAT THE EXTRA ANTIBIOTICS MAY RESULT IN EARLY LOOSENING. NO INTRAOPERATIVE COMPLICATIONS WERE REPORTED. REVISION OPERATIVE NOTES REPORTED THAT THE PATIENT WAS BEING REVISED FOR PAIN AND POTENTIAL LOOSENING. THE PATELLA WAS IN GOOD POSITION AND NOT LOOSE, SO THE SURGEON DID NOT REMOVE IT TO MAINTAIN BONE STOCK AT THE PATELLA. THE ARTICULAR SURFACE, FEMORAL AND TIBIAL COMPONENTS WERE REMOVED. NO NOTES WERE MADE ON THE CONDITION OF THE FEMORAL AND TIBIAL COMPONENTS. NO INTRAOPERATIVE COMPLICATIONS WERE REPORTED.

    Patient problems: Failure of Implant; Pain

    MAUDE report 13805911 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K181947, K191625. One submission often covers many models, so check the product and lot details in each record.

  • Z-2578-2026 · May 11, 2026 · Open, Classified
    Brand Name: Persona Revision Product Name: Persona Revision Trabecular Metal Femoral Distal Augment Model/Catalog Number: 42-5572-066-10 Software Version: N/A Product Description:

Other Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive devices

All Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer + additive/metal/polymer + additive devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page